Skip to main content
PRTA logo
PRTA
(NASDAQ)
Prothena Corporation plc
$9.30-- (--)
Loading... - Market loading

Prothena Corporation (PRTA) Stock Price & Financial Analysis

Prothena Corporation Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.22 - $9.50
52-Week High$11.80
52-Week Low$7.73
Open$9.40
Volume294.48K
Average Volume (3M)391.84K
Market Cap503.21M
Shares Outstanding54.11M
Price to Sales (P/S)8.69
Price to Book (P/B)1.61
EV/EBITDA-2.32
Revenue (TTM)57.94M
Net Income (TTM)-151.18M
Free Cash Flow (TTM)-81.43M
EPS (TTM)$-2.80
Profit Margin-260.92%
Operating Margin-160.84%
Return on Equity (ROE)-48.36%
Debt to Equity0.02
50-Day MA$9.05
200-Day MA$9.48
52-Week Change11.51%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Prothena Corporation

What is the current stock price for PRTA?

As of the latest trading session, PRTA stock trades at $9.30. The 52-week range is $7.73–$11.80, with a day range of $9.22–$9.50.

What is the P/E ratio for PRTA?

The P/E ratio (Price-to-Earnings) for PRTA is shown in the Key Statistics section. This valuation metric helps compare Prothena Corporation plc to industry peers.

Does PRTA pay dividends?

Prothena Corporation does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PRTA?

Analyst ratings and recommendations for PRTA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of PRTA?

Prothena Corporation's market capitalization is $503.2M, classifying it as a small-cap company. Prothena Corporation operates in the Healthcare sector within the Biotechnology industry.